v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Follow-On Offering
Common Stock
Common Stock
Follow-On Offering
Additional Paid-in Capital
Additional Paid-in Capital
Follow-On Offering
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2024 $ 151,970       $ 525,934     $ (374,227) $ 263
Beginning Balance, Shares at Dec. 31, 2024     49,998,279            
Stock-based compensation expense 3,514       3,514        
Employee Stock Purchase Plan issuance 96       96        
Employee Stock Purchase Plan issuance, Shares     15,263            
Vesting of restricted stock, Shares     211,770            
Unrealized loss on marketable securities (137)               (137)
Currency translation adjustment (21)               (21)
Other 27       27        
Net loss (27,483)             (27,483)  
Ending Balance at Mar. 31, 2025 127,966       529,571     (401,710) 105
Ending Balance, Shares at Mar. 31, 2025     50,225,312            
Beginning Balance at Dec. 31, 2024 151,970       525,934     (374,227) 263
Beginning Balance, Shares at Dec. 31, 2024     49,998,279            
Unrealized loss on marketable securities (226)                
Currency translation adjustment (12)                
Net loss (54,502)                
Ending Balance at Jun. 30, 2025 174,629       603,333     (428,729) 25
Ending Balance, Shares at Jun. 30, 2025     62,071,050            
Beginning Balance at Dec. 31, 2024 151,970       525,934     (374,227) 263
Beginning Balance, Shares at Dec. 31, 2024     49,998,279            
Ending Balance at Dec. 31, 2025 $ 136,913       617,433     (480,418) (102)
Ending Balance, Shares at Dec. 31, 2025     63,587,777            
Ending Balance, Shares at Dec. 31, 2025 0                
Beginning Balance at Mar. 31, 2025 $ 127,966       529,571     (401,710) 105
Beginning Balance, Shares at Mar. 31, 2025     50,225,312            
Stock-based compensation expense 3,833       3,833        
Stock option exercises 2       2        
Stock option exercises, Shares     1,424            
Vesting of restricted stock, Shares     108,749            
Unrealized loss on marketable securities (88)               (88)
Issuance of common stock   $ 46,517       $ 46,517      
Issuance of common stock, Shares       11,735,565          
Issuance of pre-funded warrants   14,156       14,156      
Issuance of common stock warrants   9,254       9,254      
Currency translation adjustment 8               8
Net loss (27,019)             (27,019)  
Ending Balance at Jun. 30, 2025 174,629       603,333     (428,729) 25
Ending Balance, Shares at Jun. 30, 2025     62,071,050            
Beginning Balance at Dec. 31, 2025 136,913       617,433     (480,418) (102)
Beginning Balance, Shares at Dec. 31, 2025     63,587,777            
Stock-based compensation expense 3,824       3,824        
Employee Stock Purchase Plan issuance 121       121        
Employee Stock Purchase Plan issuance, Shares     24,214            
Stock option exercises 56       56        
Stock option exercises, Shares     12,733            
Common stock warrant exercises 123       123        
Common stock warrant exercises, Shares     25,000            
Vesting of restricted stock, Shares     500,744            
Unrealized loss on marketable securities (78)               (78)
Currency translation adjustment (27)               (27)
Net loss (33,685)             (33,685)  
Ending Balance at Mar. 31, 2026 107,247       621,557     (514,103) (207)
Ending Balance, Shares at Mar. 31, 2026     64,150,468            
Beginning Balance at Dec. 31, 2025 136,913       617,433     (480,418) (102)
Beginning Balance, Shares at Dec. 31, 2025     63,587,777            
Unrealized loss on marketable securities (368)                
Currency translation adjustment (200)                
Net loss (79,322)                
Ending Balance at Jun. 30, 2026 $ 315,267   $ 1   914,769   $ (39,093) (559,740) (670)
Ending Balance, Shares at Jun. 30, 2026     103,480,053            
Ending Balance, Shares at Jun. 30, 2026 6,922,870           6,922,870    
Beginning Balance at Mar. 31, 2026 $ 107,247       621,557     (514,103) (207)
Beginning Balance, Shares at Mar. 31, 2026     64,150,468            
Stock-based compensation expense 12,368       12,368        
Stock option exercises 80       80        
Stock option exercises, Shares     10,720            
Vesting of restricted stock, Shares     142,085            
Unrealized loss on marketable securities (290)               (290)
Issuance of common stock   259,384   $ 1   259,383      
Issuance of common stock, Shares       46,099,650          
Issuance of pre-funded warrants   $ 21,381       $ 21,381      
Repurchase of common stock, including transaction costs (39,093)           $ (39,093)    
Repurchase of common stock, including transaction costs, Shares     (6,922,870)       6,922,870    
Currency translation adjustment (173)               (173)
Net loss (45,637)             (45,637)  
Ending Balance at Jun. 30, 2026 $ 315,267   $ 1   $ 914,769   $ (39,093) $ (559,740) $ (670)
Ending Balance, Shares at Jun. 30, 2026     103,480,053            
Ending Balance, Shares at Jun. 30, 2026 6,922,870           6,922,870